Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Details) - Schedule of Segment Reporting Information, by Segment

v3.21.2
SEGMENT REPORTING (Details) - Schedule of Segment Reporting Information, by Segment - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Aug. 03, 2021
Feb. 10, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]              
Revenue $ 108,000 $ 0 $ 433,000 $ 0      
Cost of goods sold 38,000 0 199,000 0      
Gross profit 70,000 0 234,000 0      
Research and development 1,315,000 4,911,000 4,248,000 15,556,000      
General and administrative 6,505,000 8,165,000 20,256,000 32,629,000      
Depreciation and amortization 51,000 24,000 142,000 67,000      
Total operating expenses 7,871,000 13,100,000 24,646,000 48,252,000      
Loss from operations (7,801,000) (13,100,000) (24,412,000) (48,252,000)      
Interest income and other income, net 1,000 2,000 2,000 45,000      
Loss on foreign currency translation 0 0 0 (1,000)      
Gain on settlement of debt 553,000 0 553,000 0      
Net loss (7,247,000) (13,098,000) (23,857,000) (48,208,000)      
Cash 17,535,000   17,535,000       $ 28,268,000
Accounts receivable 100,000   100,000       0
Inventory 1,881,007   1,881,007       768,319
Employee advances 50,000   50,000       0
Other current assets 433,000   433,000        
Total current assets 19,999,000   19,999,000       29,337,000
Property and equipment, net 557,000   557,000        
Right-to-use assets, net 693,000   693,000   $ 492,876 $ 217,903 306,000
Other assets 424,000   424,000        
Total assets 21,673,000   21,673,000       $ 30,386,000
Corporate Segment [Member]              
Segment Reporting Information [Line Items]              
Revenue 108,000   433,000        
Cost of goods sold 38,000   199,000        
Gross profit 70,000   234,000        
Research and development 1,311,000 698,000 4,042,000 3,112,000      
General and administrative 5,975,000 6,807,000 17,954,000 18,756,000      
Depreciation and amortization 50,000 24,000 139,000 66,000      
Total operating expenses 7,336,000 7,529,000 22,135,000 21,934,000      
Loss from operations (7,266,000) (7,529,000) (21,901,000) (21,934,000)      
Interest income and other income, net 1,000 2,000 2,000 30,000      
Loss on foreign currency translation       0      
Gain on settlement of debt 0   0        
Net loss (7,265,000) (7,527,000) (21,899,000) (21,904,000)      
Cash 15,138,000   15,138,000        
Accounts receivable 100,000   100,000        
Inventory 1,881,000   1,881,000        
Employee advances 50,000   50,000        
Other current assets 431,000   431,000        
Total current assets 17,600,000   17,600,000        
Property and equipment, net 551,000   551,000        
Right-to-use assets, net 693,000   693,000        
Other assets 424,000   424,000        
Total assets 19,268,000   19,268,000        
Viral Clear [Member]              
Segment Reporting Information [Line Items]              
Revenue 0   0        
Cost of goods sold 0   0        
Gross profit 0   0        
Research and development 4,000 4,183,000 206,000 12,414,000      
General and administrative 529,000 1,358,000 2,297,000 13,873,000      
Depreciation and amortization 1,000 0 3,000 0      
Total operating expenses 534,000 5,541,000 2,506,000 26,287,000      
Loss from operations (534,000) (5,541,000) (2,506,000) (26,287,000)      
Interest income and other income, net 0 0 0 15,000      
Loss on foreign currency translation       (1,000)      
Gain on settlement of debt 553,000   553,000        
Net loss 19,000 (5,541,000) (1,953,000) (26,273,000)      
Cash 2,397,000   2,397,000        
Accounts receivable 0   0        
Inventory 0   0        
Employee advances 0   0        
Other current assets 2,000   2,000        
Total current assets 2,399,000   2,399,000        
Property and equipment, net 6,000   6,000        
Right-to-use assets, net 0   0        
Other assets 0   0        
Total assets 2,405,000   2,405,000        
NeuroClear Technologies, Inc ("NeuroClear") [Member]              
Segment Reporting Information [Line Items]              
Revenue 0   0        
Cost of goods sold 0   0        
Gross profit 0   0        
Research and development 0 30,000 0 30,000      
General and administrative 1,000 0 5,000 0      
Depreciation and amortization 0 0 0 1,000      
Total operating expenses 1,000 30,000 5,000 31,000      
Loss from operations (1,000) (30,000) (5,000) (31,000)      
Interest income and other income, net 0 0 0 0      
Loss on foreign currency translation       0      
Gain on settlement of debt 0   0        
Net loss (1,000) (30,000) (5,000) (31,000)      
Cash 0   0        
Accounts receivable 0   0        
Inventory 0   0        
Employee advances 0   0        
Other current assets 0   0        
Total current assets 0   0        
Property and equipment, net 0   0        
Right-to-use assets, net 0   0        
Other assets 0   0        
Total assets 0   0        
Product [Member]              
Segment Reporting Information [Line Items]              
Revenue 100,000 0 414,000 0      
Product [Member] | Corporate Segment [Member]              
Segment Reporting Information [Line Items]              
Revenue 100,000   414,000        
Product [Member] | Viral Clear [Member]              
Segment Reporting Information [Line Items]              
Revenue 0   0        
Product [Member] | NeuroClear Technologies, Inc ("NeuroClear") [Member]              
Segment Reporting Information [Line Items]              
Revenue 0   0        
Service [Member]              
Segment Reporting Information [Line Items]              
Revenue 8,000 $ 0 19,000 $ 0      
Service [Member] | Corporate Segment [Member]              
Segment Reporting Information [Line Items]              
Revenue 8,000   19,000        
Service [Member] | Viral Clear [Member]              
Segment Reporting Information [Line Items]              
Revenue 0   0        
Service [Member] | NeuroClear Technologies, Inc ("NeuroClear") [Member]              
Segment Reporting Information [Line Items]              
Revenue $ 0   $ 0